Skip to main content
Home
Profiles
Research Units
Core Facilities
Sponsored Projects
Publications
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia (The DAYBREAK Study)
Knebl, Janice
(PI)
Texas College of Osteopathic Medicine
Internal Medicine & Geriatrics
Institute for Healthy Aging
Status
Active
Effective start/end date
13/10/16
→
12/10/21
Funding
Eli Lilly:
$119,311.00
View all
View less
Keywords
Aging & Alzheimers, Biotechnology & Drug Development